FCM
RNAM

Fieldview Capital Management’s Avidity Biosciences RNAM Stock Holding History

Fieldview Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,149
Closed -$227K – 684
2025
Q4 		$227K Buy
+3,149
New +$203K 0.04% 434

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Fieldview Capital Management's RNAM Position: Q1 2026 in Review

Fieldview Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 3,149 shares — an estimated $227K sold.

Fieldview Capital Management first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $227K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Fieldview Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 3,149 Avidity Biosciences shares in Q1 2026, an estimated $227K.
  • Fieldview Capital Management first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • Fieldview Capital Management's Avidity Biosciences position peaked at $227K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.